Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Production and performance of a <sup>172</sup>Hf/<sup>172</sup>Lu generator.

Scientific reports·2026
Same author

Industry-Academic Collaboration in Nuclear Medicine: Proceedings from the 2024 CMIIT Industry Partners Circle.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same author

Toward Rapid Actinium-225 Purification via Membrane Adsorbers with Covalently Tethered Diglycolamide Ligands.

ACS applied materials & interfaces·2026
Same author

Establishing Pb-203 production from electrodeposited Tl targets at Brookhaven National Laboratory.

EJNMMI radiopharmacy and chemistry·2025
Same author

FDA Investigator Training for PET Drug Manufacturing Inspections.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2025
Same author

<sup>48</sup>Ca(p,pn)<sup>47</sup>Ca linac production for the preparation of a <sup>47</sup>Ca/<sup>47</sup>Sc generator.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2025
Same journal

<sup>18</sup>F-NaF PET/CT Versus <sup>18</sup>F-FDG PET/CT for Baseline Mapping in Ollier Disease: A Pediatric Case.

Journal of nuclear medicine technology·2026
Same journal

Incidental Detection of Aggressive HER2-Positive Breast Cancer on <sup>99m</sup>Tc-Sestamibi Parathyroid Scintigraphy.

Journal of nuclear medicine technology·2026
Same journal

Structured Educational Tours in Hospital-Based Radiopharmaceutical Production: Balancing Safety and Learning.

Journal of nuclear medicine technology·2026
Same journal

Development of a Phantom for Evaluating Image Quality and Partial-Volume Effects in Hot and Cold Regions in Small-Animal SPECT and PET.

Journal of nuclear medicine technology·2026
Same journal

Nonuniformity in a Certified <sup>68</sup>Ge PET Cylinder Phantom: Implications for Normalization Quality Assurance.

Journal of nuclear medicine technology·2026
Same journal

Reducing Formation of Suspected Tracer Microemboli During Preparation of <sup>99m</sup>Tc-Tagged Heat-Damaged Red Blood Cells.

Journal of nuclear medicine technology·2026
See all related articles

Related Experiment Video

Updated: Jan 9, 2026

Author Spotlight: An Efficient and Robust Software for Automated Fusion of Multiple Preclinical Imaging Modalities
07:13

Author Spotlight: An Efficient and Robust Software for Automated Fusion of Multiple Preclinical Imaging Modalities

Published on: October 27, 2023

1.6K

SNMMI Stakeholder Theranostics Summit.

Cathy S Cutler1

  • 1Isotope Research and Production Department, Brookhaven National Laboratory, Upton, New York ccutler@bnl.gov.

Journal of Nuclear Medicine Technology
|December 4, 2025
PubMed
Summary
This summary is machine-generated.

Nuclear medicine theranostics are rapidly expanding, facing system strain and increasing complexity. A stakeholder summit convened to address challenges and ensure patient-centered care realization.

Keywords:
summittheranosticsworkshop

More Related Videos

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.8K
Live Imaging of Drug Responses in the Tumor Microenvironment in Mouse Models of Breast Cancer
08:26

Live Imaging of Drug Responses in the Tumor Microenvironment in Mouse Models of Breast Cancer

Published on: March 24, 2013

25.4K

Related Experiment Videos

Last Updated: Jan 9, 2026

Author Spotlight: An Efficient and Robust Software for Automated Fusion of Multiple Preclinical Imaging Modalities
07:13

Author Spotlight: An Efficient and Robust Software for Automated Fusion of Multiple Preclinical Imaging Modalities

Published on: October 27, 2023

1.6K
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.8K
Live Imaging of Drug Responses in the Tumor Microenvironment in Mouse Models of Breast Cancer
08:26

Live Imaging of Drug Responses in the Tumor Microenvironment in Mouse Models of Breast Cancer

Published on: March 24, 2013

25.4K

Area of Science:

  • Nuclear Medicine
  • Molecular Imaging
  • Theranostics

Background:

  • Major pharmaceutical investments are driving growth in nuclear medicine theranostics.
  • Increasing clinical trials and demand are straining healthcare systems.
  • Significant potential exists, but challenges hinder theranostics' full realization.

Purpose of the Study:

  • To address the growing demand and challenges in nuclear medicine theranostics.
  • To foster collaboration and develop practical solutions for theranostics.
  • To ensure patient-centered care in the advancement of theranostics.

Main Methods:

  • The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has implemented initiatives like Centers of Excellence and a Therapy Clinical Trials Network.
  • SNMMI hosted a stakeholder summit on May 1-3, 2025, with over 100 participants.
  • The summit aimed to broaden perspectives and develop supported solutions for theranostics.

Main Results:

  • SNMMI's initiatives have accelerated clinical practice and research in theranostics.
  • The stakeholder summit brought together diverse experts to discuss challenges.
  • A path forward was developed to realize the potential of theranostics for patients.

Conclusions:

  • The rapid growth of theranostics necessitates strategic planning and collaboration.
  • Addressing workforce, supply, and infrastructure challenges is crucial.
  • SNMMI's efforts and the stakeholder summit are vital steps toward advancing patient-centered theranostics.